Roche Holding AGROG:VTX

265.10
1.30 / 0.49%
911.84k
1.23%
0.9407
Close in CHFToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 03 2015 16:31 BST.

Consensus recommendation

As of Jun 26, 2015, the consensus forecast amongst 31 polled investment analysts covering Roche Holding Ltd. advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 02, 2003. The previous consensus forecast advised investors to hold their position in Roche Holding Ltd..

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
Buy8
Outperform15
Hold8
Underperform0
Sell0
No opinion0

Research Reports

Share price forecast

The 25 analysts offering 12 month price targets for Roche Holding Ltd. have a median target of 305.00, with a high estimate of 340.00 and a low estimate of 265.00. The median estimate represents a 16.41% increase from the last price of 262.00. View Full Financials

High+28.3 %340.00
Med+15.1 %305.00
Low0.0%265.00

Dividends

In 2014, Roche Holding AG reported a dividend of 8.00 CHF, which represents a 2.56% increase over last year. The 29 analysts covering the company expect dividends of 8.33 CHF for the upcoming fiscal year, an increase of 4.18%. View Full Financials

Div growth (TTM)+2.56%
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Jul 24, 2014, Roche Holding Ltd. reported semi annual 2014 earnings of 7.57 per share. This result was in line with the consensus of the 4 analysts following the company and under-performed last year's results for the same period by 0.13%.
The next earnings announcement is expected on Apr 22, 2015. View Full Interim Financials

Average growth rate+2.78%

Roche Holding Ltd. reported annual 2014 earnings of 14.29 per share on Jan 28, 2015. View Full Annual Financials

Average growth rate+5.96%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement

Revenue

Roche Holding AG reported semi annual 2014 revenues of 24.488bn. This bettered the 24.156bn consensus of the 4 analysts covering the company. This was 4.27% above the prior year's period results. View Full Interim Financials

Average growth rate+1.54%

Roche Holding AG had revenues for the full year 2014 of 47.462bn. This was 1.46% above the prior year's results. View Full Annual Financials

Average growth rate+0.21%
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.